Cargando…
Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study
LiverMultiScan is an emerging diagnostic tool using multiparametric MRI to quantify liver disease. In a two-centre prospective validation study, 161 consecutive adult patients who had clinically-indicated liver biopsies underwent contemporaneous non-contrast multiparametric MRI at 3.0 tesla (proton...
Autores principales: | McDonald, Natasha, Eddowes, Peter J., Hodson, James, Semple, Scott I. K., Davies, Nigel P., Kelly, Catherine J., Kin, Stella, Phillips, Miranda, Herlihy, Amy H., Kendall, Timothy J., Brown, Rachel M., Neil, Desley A. H., Hübscher, Stefan G., Hirschfield, Gideon M., Fallowfield, Jonathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003924/ https://www.ncbi.nlm.nih.gov/pubmed/29907829 http://dx.doi.org/10.1038/s41598-018-27560-5 |
Ejemplares similares
-
Multiparametric Magnetic Resonance Imaging, Autoimmune Hepatitis, and Prediction of Disease Activity
por: Arndtz, Katherine, et al.
Publicado: (2021) -
Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study
por: Hoy, Anna M., et al.
Publicado: (2018) -
A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis
por: Dennis, Andrea, et al.
Publicado: (2020) -
Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner
por: Trivedi, Palak J, et al.
Publicado: (2018) -
Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report
por: Corrigan, Margaret, et al.
Publicado: (2019)